Michael R et al. revealed that loss of DG glycosylation in ccRCC patients was associated with high mortality, with the most significant difference in the GYLTL1B gene encoding LARGE2, which was reduced by nearly 80% in ccRCC patients compared to normal controls [70]. Here, LARGE2 is linked to nonpapillary renal cell carcinoma.